Altris AI, a leading force in AI for OCT scan analysis that detects the widest range of retina pathologies and biomarkers, launches an advanced glaucoma Optic Disc Analysis module.  

Early detection of glaucoma demands exceptional precision, as the early signs are often subtle and difficult to detect. A major challenge in glaucoma screening is the high rate of false positive referrals, which can lead to unnecessary appointments in secondary care. This not only burdens healthcare systems but also causes anxiety for patients. Yet delayed or missed detection of glaucoma results in irreversible vision loss for millions of people worldwide. So the need for timely and accurate glaucoma detection has never been so critical in the eye care industry, and automated AI-powered glaucoma analysis will offer a transformative potential to improve outcomes. 

To address this critical need, Altris AI has introduced its Advanced Optic Disc (OD) Analysis, building on its earlier innovation with Ganglion Cell Complex (GCC) Asymmetry Analysis to enhance the improvements from the Altris AI macula module which has been available for several years.

Altris AI’s glaucoma detection journey began with the creation of AI-powered GCC Asymmetry Analysis, designed to detect early risk of glaucoma.

In February 2025 Altris launched the AI-powered Advanced Optic Disc (OD) Analysis module as OD analysis is regarded as the gold standard for structural glaucoma diagnosis.

This method provides a comprehensive picture of structural damage and allows detailed glaucoma assessment for treatment choice and monitoring. 

The module evaluates optic disc parameters using OCT, providing personalized assessments by accounting for individual disc sizes and angle of rim absence. This tailored approach eliminates reliance on normative databases, making evaluations more accurate and patient-specific.

Altris AI’s platform assigns a severity score for optic disc damage on a scale from 1 to 10, offering valuable insights into glaucomatous changes. Furthermore, it enables cross-evaluation across different OCT systems, allowing practitioners to analyze both macula and optic disc pathology, even when data originates from multiple OCT devices.

Optic Disc Analysis for Glaucoma: Key Parameters 

• Disc area
• Cup area
• Cup volume
• Minimal Cup depth
• Maximum Cup depth
• Cup/Disc area ratio
• Rim Absence angle
• Disc-Damage Likelihood Scale (DDLS)

The Altris AI Glaucoma Module is compatible with various OCT scan protocols, including:

• 3D OCT optic disc scans
• 3D OCT horizontal wide scans
• 3D OCT vertical-wide scans
• OCT optic disc raster scans

By combining  GCC Asymmetry and Advanced Optic Disc analysis for glaucoma empower enabling Eyecare practitioners (ECPs) to make faster evaluations and explore a wider range of treatment options. This streamlined approach empowers ECPswith timely, actionable data, ultimately improving patient outcomes and care.

Dr. Maria Znamenska, MD, PhD, and a Chief Medical Officer at Altris AI, commented:

“The launch of our Advanced Optic Disc Analysis module marks a pivotal step forward in glaucoma care. By combining the gold standard of optic disc evaluation with AI-powered precision, we’re equipping eye care professionals with the tools to make more accurate and timely diagnosis of this vision-threatening disorder. This innovation not only reduces false positive referrals but also enhances early detection and treatment planning—ensuring better outcomes for patients and optimizing healthcare resources. Together with GCC asymmetry analysis, our platform empowers clinicians to elevate the standard of glaucoma care, offering hope to millions at risk of vision loss.”

About Altris AI

Altris AI is an artificial intelligence platform for OCT analysis, capable of detecting the widest range of retinal pathologies and biomarkers on the market – more than 70. Leading the way in AI innovation, Altris AI provides transformative solutions that enhance the diagnosis, treatment, and monitoring of retinal diseases, enabling eye care professionals to deliver exceptional patient care.